- 2020 ICD-10-CM Diagnosis Code C80.1Malignant (primary) neoplasm, unspecified https://www.icd10data.com/ICD10CM/Codes/C00-D49/C76-C80/C80-/C80.1.
- Pavlidis N, Fizazi K. Carcinoma of unknown primary (CUP). Critical reviews in oncology/hematology. 2009 ;69:271-8.
- Jones, W., Allardice, G., Scott, I., Oien, K., Brewster, D., & Morrison, D. S.. Cancers of unknown primary diagnosed during hospitalization: a population-based study. BMC Cancer, 2017;17: 85.
- Dyrvig, A. K., Yderstræde, K. B., Gerke, O., Jensen, P. B., Hess, S., Høilund-Carlsen, P. F., & Green, A.. Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity. Medicine, 2017;96: e6693.
- The Netherlands Cancer Registry; 2015. https://www.iknl.nl/nkr-cijfers. Accessed?
- Cancer Research UK. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/cancer-of-unknown-primary/incidence. Accessed?
- Fizazi K, Greco FA, Pavlidis N, Pentheroudakis G; ESMO Guidelines Working Group. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol 2011;22 Suppl 6:vi64–vi68.
- Kaizu H, Ogino I, Hata M, et al. Chemoradiation as a definitive treatment for cervical lymph node metastases from unknown primary cancer. Anticancer Res 2013; 33:5187–92.
- American cancer society 2020 https://www.cancer.org/cancer/cancer-unknown-primary.html. Accessed?
- Mahmood RI, Aldehaim M, Hussain F, Elhassan TA, Khan ZA, Memon MA. Carcinoma of unknown primary: 35 years of single institution`s experience. Cancer Translational Medicine. 2016 ; 2:113.
- Qaseem, A., Usman, N., Jayaraj, J. S., Janapala, R. N., & Kashif, T. Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site. Cureus, 2019;11: e5552.
- Conway, A. M., Mitchell, C., Kilgour, E., Brady, G., Dive, C., & Cook, N. Molecular characterization and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the ‘U’out of ‘CUP’. British journal of cancer, 2019;120:41.
- Fizazi, K., Greco, F. A., Pavlidis, N., Daugaard, G., Oien, K., & Pentheroudakis, G.. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Annals of Oncology, 2015;26(suppl_5), v133-38.
- Pavlidis N, Khaled H, Gaafar R. A mini review on cancer of unknown primary site: a clinical puzzle for the oncologists. Journal of advanced research. 2015;6:375-82.
- Hemminki K, Bevier M, Hemminki A, Sundquist J. Survival in cancer of unknown primary site: population-based analysis by site and histology. Annals of oncology. 2011;23:1854-63.
- Pavlidis N, Pentheroudakis G. Cancer of unknown primary site. The Lancet. 2012 ;379:1428-35.
- Vajdic CM, Goldstien D. Cancer of unknown primary site. Australian family physicians. 2015;44:640.
- Jung KW, Won YJ, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer research and treatment: official journal of Korean Cancer Association. 2018.
- Randen M, Rutqvist LE, Johansson H. Cancer patients without a known primary: incidence and survival trends in Sweden 1960_2007. Acta Oncologica. 2009; 48:915-20.
- Rassy E, Pavlidis N. The currently declining incidence of cancer of unknown primary. Cancer 2019; 61: 139-41.
- Annual Report. Iraqi Cancer Registry 2019. Iraqi Cancer Board, Ministry of Health, Iraq, 2021.
- Worldmeter, Iraq demographics. https://www.worldometers.info/demographics/iraq-demographics/#life-exp
- Skelton M; Alameddine R, Saifi O, Hammoud M, Zorkot M, Daher M, et al. High-Cost Cancer Treatment Across Borders in Conflict Zones: Experience of Iraqi Patients in Lebanon. JCO Glob Oncol. 2020; 6: JGO.19.00281.
- Vajdic C M, Perez-Concha O, Dobbins T, R L Ward R L, A L Schaffer A L, van Leeuwen MT, Rhee JJ, Laaksonen MA, Craigen G, Pearson SA. Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP). Cancer Epidemiol. 2019; 60:156-61.
- Kaaks R, Sookthai D, Hemminiki K, Kramer A, Boeing H, Wirfalt E, Weiderpass E, Overvad K, Tjonneland A, Olsen A, Peeters PH. Risk factors for cancers of unknown primary site: results from the prospective EPIC cohort. International journal of cancer. 2014; 135:2475-81.
- Varadhachary GR, Raber MN. Cancer of unknown primary site. New England Journal of Medicine. 2014;371:757-65.
- Lu MY, Chen TY, Williamson DFK, Zhao M, Shady M, Lipkova J, Mahmood F. AI-based pathology predicts origins for cancers of unknown primary. Nature. 2021; 594:106-10.
- Shelleh HH, Depleted Uranium. Is it potentially involved in the recent upsurge of malignancies in populations exposed to war dust? Saudi Med J.2012;33: 483-88.
- StrandLA, Jan Ivar Martinsen JI, Borud A 5-Year Continued Follow-up of Cancer Risk and All-Cause Mortality Among Norwegian Military Peacekeepers Deployed to Kosovo During 1999-2016. Mil Med. 2020;185: e239-e243.
|